Production (Stage)
Lotus Bio-Technology Development Corp.
LBTD
$0.00
$0.000.00%
OTC PK
| 12/31/2017 | 09/30/2017 | 06/30/2017 | 03/31/2017 | 12/31/2016 | |
|---|---|---|---|---|---|
| Net Income | 98.37% | 96.11% | 97.68% | 97.50% | -6,231.78% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -159.26% | -131.25% | -131.25% | -100.00% | -- |
| Total Other Non-Cash Items | -97.32% | -97.32% | -99.28% | -99.28% | -- |
| Change in Net Operating Assets | -160.00% | -87.91% | -124.86% | -124.67% | 306.52% |
| Cash from Operations | 101.45% | -144.74% | -478.72% | -17,900.00% | -264.29% |
| Capital Expenditure | -- | -- | -- | -- | 200.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 200.00% |
| Total Debt Issued | -101.85% | 1,062.50% | 1,718.18% | 790.00% | 735.29% |
| Total Debt Repaid | -1,471.43% | -- | 100.00% | 100.00% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -102.74% | 444.44% | 486.96% | 1,286.67% | 529.41% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -- | 100.00% | -- |